| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |